Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The investigators propose to study the efficacy and safety of the combination of Docetaxel
plus Bevacizumab in a Phase II trial of elderly subjects with non-small cell lung cancer